查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1636000

2025-2033 年按產品、測試類型（酶聯免疫吸附測定、臨床實驗室改進修正案等）、應用和地區分類的骨骼和礦物質診斷測試市場報告

Bone and Mineral Diagnostic Testing Market Report by Product, Test Type (Enzyme-Linked Immunosorbent Assay, Clinical Laboratory Improvement Amendments, and Others), Application, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 139 Pages | 商品交期: 2-3個工作天內

價格

2024年，全球骨骼和礦物質診斷檢測市場規模達11IMARC Group美元。骨骼相關疾病發生率的大幅增加、對早期疾病診斷和預防的需求不斷增加以及自動化檢測技術的不斷進步是推動市場的一些關鍵因素。

骨骼和礦物質診斷測試可檢測骨骼和礦物質疾病，這些疾病使用 ELISA、CLIA 和 RIA 等技術進行，以診斷和評估治療反應。骨骼和礦物質代謝紊亂是一個通用術語，用於描述由於鈣、磷和維生素D 等礦物質缺乏而導致骨骼衰弱的一系列病症。並且需要最少的時間。使用 X 光、電腦斷層掃描 (CT) 掃描或磁振造影 (MRI) 可以幫助識別或排除骨折、磨損和異常骨骼位置。此外，骨密度測試（也稱為骨密度測定或骨密度測定）和骨掃描（骨閃爍掃描）可檢測骨骼中的礦物質、骨代謝的詳細資訊，並描繪不同的骨骼結構。除此之外，骨骼活體組織切片和骨髓活體組織切片也是骨骼診斷測試的重要形式，其中使用細針去除骨組織以檢測與疾病相關的變化。

骨骼和礦物質診斷測試市場趨勢：

全球骨相關疾病發生率的大幅增加是推動市場的重要因素。這可以歸因於久坐的生活方式導致維生素 D 缺乏的現像日益普遍。此外，自動化檢測技術的不斷進步，增強了診斷測試的能力，縮短了周轉時間，提高了產出的準確性，正在為市場創造利潤豐厚的成長機會。然而，幾種骨診斷測試的成本增加、報銷有限以及檢測能力有限是限制市場成長的重要因素。相反，廣泛的現場護理 (POC) 診斷測試的擴展以及公眾對預防性醫療保健意識的大幅提高正在為市場創造積極的前景。政府和非營利組織為提高大眾對各種診斷測試程序的認知而採取的有利舉措進一步推動了市場。除此之外，越來越多的老年人口更容易罹患這些疾病，導致骨骼疾病的發生率不斷增加。促進市場發展的其他一些因素包括快速城市化、醫療支出增加、製造商推出新產品以及廣泛的研發 (R&D) 活動。

本報告回答的關鍵問題：

  • 迄今為止，全球骨骼和礦物質診斷測試市場的表現如何，未來幾年將如何表現？
  • 全球骨骼和礦物質診斷測試市場的促進因素、限制因素和機會是什麼？
  • 主要區域市場有哪些？
  • 哪些國家代表了最具吸引力的骨骼和礦物質診斷測試市場？
  • 基於產品的市場區隔是什麼？
  • 根據測試類型，市場的細分是什麼？
  • 基於應用程式的市場區隔是什麼？
  • 全球骨骼和礦物質診斷檢測市場的競爭結構如何？
  • 全球骨骼和礦物質診斷測試市場的主要參與者/公司有哪些？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 數據來源
    • 主要來源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球骨骼和礦物質診斷測試市場

  • 市場概況
  • 市場表現
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依產品

  • 化驗/耗材
    • 市場趨勢
    • 市場預測
  • 儀器儀表
    • 市場趨勢
    • 市場預測

第 7 章：市場區隔：按測試類型

  • 酵素連結免疫吸附測定法 (ELISA)
    • 市場趨勢
    • 市場預測
  • 臨床實驗室改進修正案 (CLIA)
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 8 章：市場區隔：按應用

  • 維生素 D 測試
    • 市場趨勢
    • 市場預測
  • 骨代謝
    • 市場趨勢
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場趨勢
    • 市場細分：按國家/地區
    • 市場預測

第 10 章：促進因素、限制與機會

  • 概述
  • 促進要素
  • 限制
  • 機會

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abbott Laboratories
    • bioMerieux SA
    • DiaSorin SpA
    • Epitope Diagnostics Inc.
    • F. Hoffmann-La Roche AG
    • QuidelOrtho Corporation
    • Siemens Healthineers AG (Siemens AG)
Product Code: SR112024A7106

The global bone and mineral diagnostic testing market size reached USD 1.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 1.5 Billion by 2033, exhibiting a growth rate (CAGR) of 3.48% during 2025-2033. A considerable increase in the incidences of bone-related diseases, the escalating demand for early disease diagnosis and prevention, and continual technological advancements in the automation of assay represent some of the key factors driving the market.

Bone and mineral diagnostic tests detect bone and mineral disorders that are performed using technologies, such as ELISA, CLIA, and RIA, to diagnose and assess treatment response. A bone and mineral metabolism disorder is a general term used to describe a range of conditions that can weaken bones due to mineral deficiencies like calcium, phosphorus, and vitamin D. In most cases, these tests are non-invasive, painless, and require minimal medication or administration, and several bone and mineral diagnostic tests are often performed using a combination method. The use of X-rays, computed tomography (CT) scans, or magnetic resonance imaging (MRI) can help identify or rule out fractures, wear and tear, and abnormal bone positions. Additionally, bone density tests (also known as bone densitometry or osteodensitometry) and bone scans (bone scintigraphy) detect the minerals in the bones, details on bone metabolism, and depict the different bone structures. Besides this, bone biopsies and bone marrow biopsies are also important forms of bone diagnostic testing, in which a thin needle is used to remove bone tissue to detect disease-related changes.

Bone and Mineral Diagnostic Testing Market Trends:

A considerable increase in the incidences of bone-related diseases on the global level is a significant factor driving the market. This can be attributed to the rising prevalence of sedentary lifestyle leading to deficiency of vitamin D. In line with this, the escalating demand for early disease diagnosis and prevention is also resulting in a higher uptake of various tests among the masses. Moreover, continual technological advancements in the automation of assay for enhanced diagnostic testing with lower turnaround times and increased accuracy in output are creating lucrative growth opportunities in the market. However, the augmenting costs of several bone diagnostic tests, limited reimbursements, along with limited detection capability are acting as significant factors that are restraining the market growth. On the contrary, the expansion of a wide range of point-of-care (POC) diagnostic tests and a considerable rise in public awareness toward preventive healthcare is creating a positive outlook for the market. The market is further driven by favorable initiatives undertaken by the government and non-profit organizations for promoting awareness about various diagnostic test procedures among the masses. Apart from this, the growing geriatric population that is more susceptible to developing these ailments is leading to the increasing incidences of bone disorders. Some of the other factors contributing to the market include rapid urbanization, rising medical expenditure, new product launches by the manufacturers, and extensive research and development (R&D) activities.

Key Market Segmentation:

Product Insights

Assays/Consumables

Instruments

Test Type Insights

Enzyme-Linked Immunosorbent Assay (ELISA)

Clinical Laboratory Improvement Amendments (CLIA)

Others

Application Insights

Vitamin D Testing

Bone Metabolism

Regional Insights

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for bone and mineral diagnostic testing. Some of the factors driving the North America bone and mineral diagnostic testing market include the expanding geriatric population, rising healthcare expenditure, extensive research and development (R&D) activities conducted by key players, etc.

Competitive Landscape

The report has also provided a comprehensive analysis of the competitive landscape in the global bone and mineral diagnostic testing market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Abbott Laboratories, bioMerieux SA, DiaSorin S.p.A., Epitope Diagnostics Inc., F. Hoffmann-La Roche AG, QuidelOrtho Corporation, Siemens Healthineers AG (Siemens AG), etc.

Key Questions Answered in This Report:

  • How has the global bone and mineral diagnostic testing market performed so far and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global bone and mineral diagnostic testing market?
  • What are the key regional markets?
  • Which countries represent the most attractive bone and mineral diagnostic testing markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the test type?
  • What is the breakup of the market based on the application?
  • What is the competitive structure of the global bone and mineral diagnostic testing market?
  • Who are the key players/companies in the global bone and mineral diagnostic testing market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Bone and Mineral Diagnostic Testing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Assays/Consumables
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Instruments
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Test Type

  • 7.1 Enzyme-Linked Immunosorbent Assay (ELISA)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Clinical Laboratory Improvement Amendments (CLIA)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Vitamin D Testing
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Bone Metabolism
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

  • 10.1 Overview
  • 10.2 Drivers
  • 10.3 Restraints
  • 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 bioMerieux SA
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 DiaSorin S.p.A.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Epitope Diagnostics Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 F. Hoffmann-La Roche AG
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
    • 14.3.6 QuidelOrtho Corporation
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Siemens Healthineers AG (Siemens AG)
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Bone and Mineral Diagnostic Testing Market: Major Drivers and Challenges
  • Figure 2: Global: Bone and Mineral Diagnostic Testing Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Bone and Mineral Diagnostic Testing Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Bone and Mineral Diagnostic Testing Market: Breakup by Test Type (in %), 2024
  • Figure 6: Global: Bone and Mineral Diagnostic Testing Market: Breakup by Application (in %), 2024
  • Figure 7: Global: Bone and Mineral Diagnostic Testing Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Bone and Mineral Diagnostic Testing (Assays/Consumables) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Bone and Mineral Diagnostic Testing (Assays/Consumables) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Bone and Mineral Diagnostic Testing (Instruments) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Bone and Mineral Diagnostic Testing (Instruments) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Bone and Mineral Diagnostic Testing (Enzyme-Linked Immunosorbent Assay (ELISA)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Bone and Mineral Diagnostic Testing (Enzyme-Linked Immunosorbent Assay (ELISA)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Bone and Mineral Diagnostic Testing (Clinical Laboratory Improvement Amendments (CLIA)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Bone and Mineral Diagnostic Testing (Clinical Laboratory Improvement Amendments (CLIA)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Bone and Mineral Diagnostic Testing (Other Test Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Bone and Mineral Diagnostic Testing (Other Test Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Bone and Mineral Diagnostic Testing (Vitamin D Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Bone and Mineral Diagnostic Testing (Vitamin D Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Bone and Mineral Diagnostic Testing (Bone Metabolism) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Bone and Mineral Diagnostic Testing (Bone Metabolism) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: North America: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: North America: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: United States: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: United States: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Canada: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Canada: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Asia-Pacific: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Asia-Pacific: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: China: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: China: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Japan: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Japan: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: India: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: India: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: South Korea: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: South Korea: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Australia: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Australia: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Indonesia: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Indonesia: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Others: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Others: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Europe: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Europe: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Germany: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Germany: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: France: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: France: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: United Kingdom: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: United Kingdom: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Italy: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Italy: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Spain: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Spain: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Russia: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Russia: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Others: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Others: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Latin America: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Latin America: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Brazil: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Brazil: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Mexico: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Mexico: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Others: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Others: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Middle East and Africa: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Middle East and Africa: Bone and Mineral Diagnostic Testing Market: Breakup by Country (in %), 2024
  • Figure 70: Middle East and Africa: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Global: Bone and Mineral Diagnostic Testing Industry: Drivers, Restraints, and Opportunities
  • Figure 72: Global: Bone and Mineral Diagnostic Testing Industry: Value Chain Analysis
  • Figure 73: Global: Bone and Mineral Diagnostic Testing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Bone and Mineral Diagnostic Testing Market: Key Industry Highlights, 2024 & 2033
  • Table 2: Global: Bone and Mineral Diagnostic Testing Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Bone and Mineral Diagnostic Testing Market Forecast: Breakup by Test Type (in Million USD), 2025-2033
  • Table 4: Global: Bone and Mineral Diagnostic Testing Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 5: Global: Bone and Mineral Diagnostic Testing Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Bone and Mineral Diagnostic Testing Market: Competitive Structure
  • Table 7: Global: Bone and Mineral Diagnostic Testing Market: Key Players